IdB HOLDING S.p.A – Trademark Portfolio
Entity Type: 03
IdB HOLDING S.p.A holds 17 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 1 (Chemicals) — 13 filings in this category. The portfolio also extends into Class 3 (Cosmetics & Cleaning) across 3 Nice Classification classes. Currently, 6 trademarks are registered. Notable registered marks include SILIPHOS, COSMELENE, GREENSELECT, MIRTOSELECT, and SABALSELECT. The owner is based in Milan.
Viale Ortles, 12
Milan , IT
Showing of trademarks Trademarks
Trademark Classifications
IdB HOLDING S.p.A's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does IdB HOLDING S.p.A have?
IdB HOLDING S.p.A has 17 U.S. trademarks filed with the USPTO. Of these, 6 registered, 10 cancelled.
What trademark classes does IdB HOLDING S.p.A file in?
IdB HOLDING S.p.A files trademarks across 3 Nice Classification classes. The most active classes are Class 1 (Chemicals), Class 3 (Cosmetics & Cleaning), Class 5 (Pharmaceuticals). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.
What are IdB HOLDING S.p.A's most well-known trademarks?
IdB HOLDING S.p.A's registered trademark portfolio includes well-known marks such as SILIPHOS, COSMELENE, GREENSELECT, MIRTOSELECT, and SABALSELECT. These are among 6 currently registered trademarks in the portfolio.
What is IdB HOLDING S.p.A's trademark registration success rate?
IdB HOLDING S.p.A has a 38% trademark registration rate, with 6 out of 16 resolved applications resulting in successful registration. Currently, 0 applications are pending review.